FDA Approves Emcitate for MCT8 Deficiency: Evidence, Safety and India Status Explained
FDA approval of tiratricol (Emcitate) for peripheral thyrotoxicosis in MCT8 deficiency: what changed, evidence limits, safety and India implications.